Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2-17-year-old children with asplenia or splenic dysfunction: A phase 3 study.
Szenborn L, Osipova IV, Czajka H, Kharit SM, Jackowska T, François N, Habib MA, Borys D. Szenborn L, et al. Among authors: osipova iv. Vaccine. 2017 Sep 25;35(40):5331-5338. doi: 10.1016/j.vaccine.2017.08.039. Epub 2017 Aug 31. Vaccine. 2017. PMID: 28866290 Free article. Clinical Trial.
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.
Asatryan A, Meyer N, Scherbakov M, Romanenko V, Osipova I, Galustyan A, Shamsheva O, Latysheva T, Myasnikova T, Baudson N, Dodet M, Xavier S, Harrington L, Kuznetsova A, Campora L, Van den Steen P. Asatryan A, et al. Hum Vaccin Immunother. 2021 Mar 4;17(3):723-730. doi: 10.1080/21645515.2020.1796423. Epub 2020 Aug 26. Hum Vaccin Immunother. 2021. PMID: 32845735 Free PMC article. Clinical Trial.
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study.
Romanenko V, Osipova I, Galustyan A, Scherbakov M, Baudson N, Farhi D, Anaya L, Kuriyakose SO, Meyer N, Janssens W. Romanenko V, et al. Hum Vaccin Immunother. 2020 Sep 1;16(9):2265-2273. doi: 10.1080/21645515.2020.1720437. Epub 2020 Feb 12. Hum Vaccin Immunother. 2020. PMID: 32048889 Free PMC article. Clinical Trial.
[Physical training at ambulatory-polyclinical stage in complex rehabilitation and secondary prevention of patients with ischemic heart disease after acute incidents. Effect on physical working capacity, hemodynamics, blood lipids, clinical course and prognosis (Russian cooperative study)].
Aronov DM, Krasnitskiĭ VB, Bubnova MG, Pozdniakov IuM, Ioseliani DG, Shchegol'kov AN, Efremushkin GG, Osipova IV, Guliaeva SF, Mal'chikova SV, Kazakevich EV, Liamina NP, Riamzina IN, Mingazetdinova LN, Galiautdinov GS, Tin'kov AN, Grinshteĭn IuI, Novikova NK. Aronov DM, et al. Among authors: osipova iv. Kardiologiia. 2009;49(3):49-56. Kardiologiia. 2009. PMID: 19257867 Clinical Trial. Russian.
The management of acute myocardial infarction in the Russian Federation: protocol for a study of patient pathways.
Kontsevaya A, Bobrova N, Barbarash O, Duplyakov D, Efanov A, Galyavich A, Frants M, Khaisheva L, Malorodova T, Mirolyubova O, Nedbaikin A, Osipova I, Platonov D, Posnenkova O, Syromiatnikova L, Bates K, Leon DA, McKee M. Kontsevaya A, et al. Wellcome Open Res. 2017 Sep 25;2:89. doi: 10.12688/wellcomeopenres.12478.2. eCollection 2017. Wellcome Open Res. 2017. PMID: 29774243 Free PMC article.
41 results